SCHEMBL3769422

SCHEMBL3769422

Cc1cccc(C)c1N1CCN(CC(=O)N2CCN(C(C)C)CC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
MAPT P10636 6/20 0.55
POLB P06746 1/20 0.55
PKM P14618 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 2/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TP53 P04637 1/20 0.46
LMNA P02545 3/20 0.46
GAA P10253 2/20 0.46
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
ATM Q13315 1/20 0.42
HTT P42858 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3777268 0.89 ALDH1A1 (0.52) ALDH1A1MAPTPOLBPKMNPSR1
SCHEMBL3761233 0.88 MAPT (0.64) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL3762814 0.82 MAPT (0.78) ALDH1A1MAPTPKMNPSR1MEN1
SCHEMBL3765839 0.81 ALDH1A1 (0.58) ALDH1A1MAPTPKMNPSR1MEN1
SCHEMBL3776078 0.81 MAPT (0.59) ALDH1A1MAPTPOLBPKMNPSR1
SCHEMBL26231958 0.80 ALDH1A1 (0.49) ALDH1A1MAPTPOLBPKMMEN1
SCHEMBL13004984 0.80 GAA (0.55) ALDH1A1MAPTPKMNPSR1KDM4E
SCHEMBL3773777 0.80 ALDH1A1 (0.52) ALDH1A1MAPTPKMNPSR1MEN1
SCHEMBL3770042 0.79 MEN1 (0.73) ALDH1A1MAPTPKMNPSR1MEN1
SCHEMBL3770303 0.79 ALDH1A1 (0.51) ALDH1A1MAPTPOLBPKMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
WO-2007016496-A2 DIPIPERAZINYL KETONES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 ALDH1A1 1210/4885MAPT 1475/4885POLB 4363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.